Evidence map›Paper›PMID 19727899›Full record

ArticleJournal of neurology2010

Neurologic complications in adult living donor liver transplant patients: an underestimated factor?

Fuat Hakan Saner, Julia Gensicke, Steven W M Olde Damink, Goran Pavlaković, Juergen Treckmann, Marc Dammann, Gernot M Kaiser, Georgios C Sotiropoulos, Arnold Radtke, Susanne Koeppen and 6 more

Abstract read
In one paragraph

Article in Journal of neurology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Prevalence of cerebrovascular diseases that can cause hemorrhagic stroke in liver transplantation recipients: a 6-year comparative study with 24,681 healthy adults.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  4. Factors Associated With Neurobehavioral Complications in Pediatric Abdominal Organ Transplant Recipients Identified Using Computable Composite Definitions.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2020
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Nutrition in the management of cirrhosis and its neurological complications.Journal of clinical and experimental hepatology · 2014
    Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Fuat Hakan SanerDepartment of General-, Visceral- and Transplant Surgery, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany. fuat.saner@uni-due.de
Julia Gensicke
Steven W M Olde Damink
Goran Pavlaković
Juergen Treckmann
Marc Dammann
Gernot M Kaiser
Georgios C Sotiropoulos
Arnold Radtke
Susanne Koeppen
Susanne Beckebaum
Vito Cicinnati
Silvio Nadalin
Massimo Malagó
Andreas Paul
Christoph E Broelsch

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver transplantation is the only curative treatment in patients with end-stage liver disease. Neurological complications (NC) are increasingly reported to occur in patients after cadaveric liver transplantation. This retrospective cohort study aims to evaluate the incidence and causes of NC in living donor liver transplant (LDLT) patients in our transplant center. Between August 1998 and December 2005, 121 adult LDLT patients were recruited into our study. 17% of patients experienced NC, and it occurred significantly more frequently in patients with alcoholic cirrhosis (42%) and autoimmune hepatitis (43%) as compared with patients with hepatitis B or C (9/10%, P = 0.013). The most common NC was encephalopathy (47.6%) followed by seizures (9.5%). The choice of immunosuppression by calcineurin inhibitor (Tacrolimus or Cyclosporin A) showed no significant difference in the incidence of NC (19 vs. 17%). The occurrence of NC did not influence the clinical outcome, since mortality rate, median ICU stay and length of hospital stay were similar between the two groups. Most patients who survived showed a nearly complete recovery of their NC. NCs occur in approximately 1 in 6 patients after LDLT and seem to be predominantly transient in nature, without major impact on clinical outcome.

Indexed as

Brain DiseasesCohort StudiesCyclosporineFemaleHepatitis, AutoimmuneHepatitis BHepatitis CHumansImmunosuppressive AgentsIncidenceLiver Cirrhosis, AlcoholicLiver DiseasesLiver TransplantationMaleMiddle AgedNervous System DiseasesCyclosporineImmunosuppressive AgentsTacrolimus

Identifiers

PMID19727899
PMCPMC2910891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.